5th February 2020
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs announces the resignation of Dave Tapolczay as non-executive Chairman of the Nuformix Board of Directors with immediate effect. Download News